Multifaceted p21 in carcinogenesis, stemness of tumor and tumor therapy
نویسندگان
چکیده
منابع مشابه
Cancer metabolism, stemness and tumor recurrence
Here, we interrogated head and neck cancer (HNSCC) specimens (n = 12) to examine if different metabolic compartments (oxidative vs. glycolytic) co-exist in human tumors. A large panel of well-established biomarkers was employed to determine the metabolic state of proliferative cancer cells. Interestingly, cell proliferation in cancer cells, as marked by Ki-67 immunostaining, was strictly correl...
متن کاملHuman Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21 in Cervical Carcinogenesis
The E7 oncoprotein of the high-risk human papillomaviruses (HPV) is thought to contribute to cervical carcinogenesis at least in part by abrogating cell cycle regulation. E7 can dysregulate the cell cycle through its interaction with several cellular proteins including the retinoblastoma suppressor protein pRb, as well as the cyclin-dependent kinase inhibitor p21. Inactivation of pRb in cervica...
متن کاملStemness Gene Profiles of Circulating Tumor Cells
Circulating tumor cells (CTCs) are a population of tumor-derived cells that detach from the primary tumor and initiate metastasis. However, the mechanisms of this process are still unknown. This phenomenon renders CTCs as a valuable resource for prognosis and diagnosis of cancer. The involvement of stemness transcription factors and markers, such as NANOG, OCT3/4, CD34, NESTIN, and SOX2, in met...
متن کاملTumor promoters and cocarcinogens in tobacco carcinogenesis.
Cigarette smoke induces carcinoma of the larynx in Syrian golden hamsters and is active as a tumor promoter in hamsters pretreated with a low dose of a PAH, nitrosamine, or nitrosamide. These tumorigenic effects are only observed with total smoke, but not with the gas phase alone. This demonstrates that the tumorigenic agents reside primarily in the particulate phase. According to fractionation...
متن کاملEGFR inhibitors may induce tumor stemness.
EGFR inhibitors spur tumor cells to express CD61 and become more stem cell-like. A combination treatment that includes bortezomib might reverse these changes.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Stem Cells
سال: 2020
ISSN: 1948-0210
DOI: 10.4252/wjsc.v12.i6.481